Researchers have unveiled a novel approach to tackle obesity by targeting fat absorption in the small intestine. The ...

Therapies that deliver hydrogen sulfide to cells could one day become the basis of new treatments for obesity and related ...

The $200B GLP-1 market is set to expand with 16 new obesity drugs launching by 2029, challenging Novo Nordisk and Eli Lilly's ...

John M. Burke, MD, examines how new obesity treatments, such as GLP-1 agonists, might influence future cancer rates.

The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...

Allowing Medicare to cover anti-obesity medications would drive up federal spending by about $35 billion on net between 2026 and 2034, according to ...

Ilant estimates that behavioral therapy can help many people lose up to 5% of their weight, anti-obesity medications can help ...

The FDA cleared a drug-free capsule for weight management in adults with a BMI of 25-40, said maker Epitomee Medical. Once ...

Metsera, a biotech focused on obesity treatments, came out of stealth only this year, and its lead drug is still in early ...

Updated European guidelines for metabolic dysfunction–associated steatotic liver disease stressed a higher risk in people ...

providing important new insights into cost considerations surrounding surgical and drug treatment of obesity. "Bariatric ...

The United States has passed peak obesity, according to new data, suggesting that the sweeping uptake of weight-loss drugs ...